25 XP   0   0   10

Corline Biomedical AB
Buy, Hold or Sell?

Let's analyse Corline together

PenkeI guess you are interested in Corline Biomedical AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Corline Biomedical AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Corline Biomedical AB

I send you an email if I find something interesting about Corline Biomedical AB.

Quick analysis of Corline (30 sec.)










What can you expect buying and holding a share of Corline? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr4.34
Expected worth in 1 year
kr4.28
How sure are you?
35.9%

+ What do you gain per year?

Total Gains per Share
kr-0.06
Return On Investment
-0.5%

For what price can you sell your share?

Current Price per Share
kr11.95
Expected price per share
kr11.05 - kr15.00
How sure are you?
50%

1. Valuation of Corline (5 min.)




Live pricePrice per Share (EOD)

kr11.95

Intrinsic Value Per Share

kr-7.01 - kr-8.18

Total Value Per Share

kr-2.67 - kr-3.84

2. Growth of Corline (5 min.)




Is Corline growing?

Current yearPrevious yearGrowGrow %
How rich?$8.7m$8.7m$96.9k1.1%

How much money is Corline making?

Current yearPrevious yearGrowGrow %
Making money-$42.4k$54.7k-$97.1k-228.8%
Net Profit Margin-8.0%5.3%--

How much money comes from the company's main activities?

3. Financial Health of Corline (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#701 / 1031

Most Revenue
#531 / 1031

Most Profit
#175 / 1031

Most Efficient
#486 / 1031

What can you expect buying and holding a share of Corline? (5 min.)

Welcome investor! Corline's management wants to use your money to grow the business. In return you get a share of Corline.

What can you expect buying and holding a share of Corline?

First you should know what it really means to hold a share of Corline. And how you can make/lose money.

Speculation

The Price per Share of Corline is kr11.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Corline.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Corline, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr4.34. Based on the TTM, the Book Value Change Per Share is kr-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.53 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Corline.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%-0.010.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.050.4%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.050.4%0.010.1%0.010.1%
Usd Price Per Share1.40-1.26-0.98-1.33-1.12-
Price to Earnings Ratio-133.42-81.69-36.62--74.24--55.06-
Price-to-Total Gains Ratio-533.69-317.71-223.11--235.27--183.38-
Price to Book Ratio3.43-3.06-2.42-4.48-5.01-
Price-to-Total Gains Ratio-533.69-317.71-223.11--235.27--183.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1233
Number of shares890
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (890 shares)-1.247.47
Gains per Year (890 shares)-4.9629.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-5-1503020
20-10-2006050
30-15-2509080
40-20-300119110
50-25-350149140
60-30-400179170
70-35-450209200
80-40-500239230
90-45-550269260
100-50-600299290

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%5.07.00.041.7%5.015.00.025.0%5.034.00.012.8%5.034.00.012.8%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%9.011.00.045.0%14.022.03.035.9%14.022.03.035.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.039.00.0%0.00.039.00.0%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%9.011.00.045.0%14.022.03.035.9%14.022.03.035.9%

Fundamentals of Corline

About Corline Biomedical AB

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company's products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; and CHC, which is used for the treatment of soft tissue injuries. The company was incorporated in 1991 and is based in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-03-08 16:34:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Corline Biomedical AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Corline earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Corline to the Biotechnology industry mean.
  • A Net Profit Margin of -9.6% means that kr-0.10 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Corline Biomedical AB:

  • The MRQ is -9.6%. The company is making a loss. -1
  • The TTM is -8.0%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-8.0%-1.6%
TTM-8.0%YOY5.3%-13.3%
TTM-8.0%5Y-377.9%+369.9%
5Y-377.9%10Y-530.2%+152.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-171.8%+162.2%
TTM-8.0%-205.8%+197.8%
YOY5.3%-262.1%+267.4%
5Y-377.9%-455.6%+77.7%
10Y-530.2%-589.0%+58.8%
1.1.2. Return on Assets

Shows how efficient Corline is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Corline to the Biotechnology industry mean.
  • -0.6% Return on Assets means that Corline generated kr-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Corline Biomedical AB:

  • The MRQ is -0.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-0.4%-0.2%
TTM-0.4%YOY0.6%-1.0%
TTM-0.4%5Y-1.7%+1.3%
5Y-1.7%10Y-2.7%+1.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-12.5%+11.9%
TTM-0.4%-12.2%+11.8%
YOY0.6%-11.2%+11.8%
5Y-1.7%-13.4%+11.7%
10Y-2.7%-14.7%+12.0%
1.1.3. Return on Equity

Shows how efficient Corline is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Corline to the Biotechnology industry mean.
  • -0.6% Return on Equity means Corline generated kr-0.01 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Corline Biomedical AB:

  • The MRQ is -0.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-0.5%-0.2%
TTM-0.5%YOY0.6%-1.1%
TTM-0.5%5Y-1.9%+1.4%
5Y-1.9%10Y-3.6%+1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.6%-15.8%+15.2%
TTM-0.5%-15.7%+15.2%
YOY0.6%-13.9%+14.5%
5Y-1.9%-18.3%+16.4%
10Y-3.6%-19.2%+15.6%

1.2. Operating Efficiency of Corline Biomedical AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Corline is operating .

  • Measures how much profit Corline makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Corline to the Biotechnology industry mean.
  • An Operating Margin of -0.3% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Corline Biomedical AB:

  • The MRQ is -0.3%. The company is operating very inefficient. -2
  • The TTM is -5.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-5.6%+5.2%
TTM-5.6%YOY5.3%-10.9%
TTM-5.6%5Y-377.4%+371.8%
5Y-377.4%10Y-258.1%-119.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3%-299.1%+298.8%
TTM-5.6%-210.1%+204.5%
YOY5.3%-279.7%+285.0%
5Y-377.4%-459.9%+82.5%
10Y-258.1%-596.9%+338.8%
1.2.2. Operating Ratio

Measures how efficient Corline is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are kr1.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Corline Biomedical AB:

  • The MRQ is 1.003. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.056. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.003TTM1.056-0.052
TTM1.056YOY0.947+0.109
TTM1.0565Y4.699-3.643
5Y4.69910Y6.222-1.523
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0032.861-1.858
TTM1.0563.193-2.137
YOY0.9473.615-2.668
5Y4.6995.560-0.861
10Y6.2227.396-1.174

1.3. Liquidity of Corline Biomedical AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Corline is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.51 means the company has kr3.51 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Corline Biomedical AB:

  • The MRQ is 3.505. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.095. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.505TTM4.095-0.590
TTM4.095YOY5.542-1.447
TTM4.0955Y5.140-1.045
5Y5.14010Y4.006+1.134
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5053.986-0.481
TTM4.0954.440-0.345
YOY5.5425.552-0.010
5Y5.1406.158-1.018
10Y4.0066.492-2.486
1.3.2. Quick Ratio

Measures if Corline is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Corline to the Biotechnology industry mean.
  • A Quick Ratio of 3.27 means the company can pay off kr3.27 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Corline Biomedical AB:

  • The MRQ is 3.275. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.676. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.275TTM3.676-0.402
TTM3.676YOY4.966-1.290
TTM3.6765Y4.818-1.142
5Y4.81810Y3.710+1.108
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2753.638-0.363
TTM3.6764.168-0.492
YOY4.9665.515-0.549
5Y4.8186.012-1.194
10Y3.7106.209-2.499

1.4. Solvency of Corline Biomedical AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Corline assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Corline to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.07 means that Corline assets are financed with 6.8% credit (debt) and the remaining percentage (100% - 6.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Corline Biomedical AB:

  • The MRQ is 0.068. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.070. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.068TTM0.070-0.002
TTM0.070YOY0.069+0.000
TTM0.0705Y0.076-0.006
5Y0.07610Y0.122-0.046
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0680.335-0.267
TTM0.0700.330-0.260
YOY0.0690.267-0.198
5Y0.0760.367-0.291
10Y0.1220.378-0.256
1.4.2. Debt to Equity Ratio

Measures if Corline is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Corline to the Biotechnology industry mean.
  • A Debt to Equity ratio of 7.3% means that company has kr0.07 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Corline Biomedical AB:

  • The MRQ is 0.073. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.075. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.073TTM0.075-0.002
TTM0.075YOY0.074+0.000
TTM0.0755Y0.083-0.008
5Y0.08310Y0.205-0.123
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0730.376-0.303
TTM0.0750.398-0.323
YOY0.0740.334-0.260
5Y0.0830.429-0.346
10Y0.2050.476-0.271

2. Market Valuation of Corline Biomedical AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Corline generates.

  • Above 15 is considered overpriced but always compare Corline to the Biotechnology industry mean.
  • A PE ratio of -133.42 means the investor is paying kr-133.42 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Corline Biomedical AB:

  • The EOD is -107.006. Based on the earnings, the company is expensive. -2
  • The MRQ is -133.422. Based on the earnings, the company is expensive. -2
  • The TTM is 81.692. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-107.006MRQ-133.422+26.416
MRQ-133.422TTM81.692-215.115
TTM81.692YOY36.622+45.071
TTM81.6925Y-74.245+155.937
5Y-74.24510Y-55.055-19.189
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-107.006-2.643-104.363
MRQ-133.422-2.418-131.004
TTM81.692-2.742+84.434
YOY36.622-4.123+40.745
5Y-74.245-6.257-67.988
10Y-55.055-6.478-48.577
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Corline Biomedical AB:

  • The EOD is 5,350.318. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 6,671.108. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1,681.933. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5,350.318MRQ6,671.108-1,320.790
MRQ6,671.108TTM1,681.933+4,989.175
TTM1,681.933YOY-15.381+1,697.315
TTM1,681.9335Y321.836+1,360.097
5Y321.83610Y160.071+161.765
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5,350.318-3.244+5,353.562
MRQ6,671.108-2.939+6,674.047
TTM1,681.933-3.478+1,685.411
YOY-15.381-5.592-9.789
5Y321.836-8.473+330.309
10Y160.071-8.881+168.952
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Corline is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.43 means the investor is paying kr3.43 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Corline Biomedical AB:

  • The EOD is 2.752. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.431. Based on the equity, the company is fair priced.
  • The TTM is 3.057. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.752MRQ3.431-0.679
MRQ3.431TTM3.057+0.374
TTM3.057YOY2.420+0.637
TTM3.0575Y4.483-1.425
5Y4.48310Y5.013-0.530
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.7522.124+0.628
MRQ3.4312.041+1.390
TTM3.0572.118+0.939
YOY2.4202.915-0.495
5Y4.4833.682+0.801
10Y5.0134.114+0.899
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Corline Biomedical AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.028-0.015-47%0.532-105%0.089-131%0.111-125%
Book Value Per Share--4.3424.381-1%4.333+0%3.498+24%2.506+73%
Current Ratio--3.5054.095-14%5.542-37%5.140-32%4.006-13%
Debt To Asset Ratio--0.0680.070-2%0.069-2%0.076-11%0.122-44%
Debt To Equity Ratio--0.0730.075-3%0.074-2%0.083-12%0.205-65%
Dividend Per Share----0%-0%-0%-0%
Eps---0.028-0.021-25%0.027-203%-0.053+89%-0.060+114%
Free Cash Flow Per Share--0.001-0.113+20381%-0.180+32289%-0.167+29928%-0.137+24660%
Free Cash Flow To Equity Per Share--0.001-0.101+18144%-0.179+32181%0.228-100%0.148-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---8.179--------
Intrinsic Value_10Y_min---7.009--------
Intrinsic Value_1Y_max---0.637--------
Intrinsic Value_1Y_min---0.626--------
Intrinsic Value_3Y_max---2.054--------
Intrinsic Value_3Y_min---1.958--------
Intrinsic Value_5Y_max---3.638--------
Intrinsic Value_5Y_min---3.365--------
Market Cap256815060.000-25%320213203.100287385977.078+11%224848272.970+42%317394397.925+1%264252417.855+21%
Net Profit Margin---0.096-0.080-17%0.053-282%-3.779+3833%-5.302+5417%
Operating Margin---0.003-0.056+1558%0.053-106%-3.774+112115%-2.581+76631%
Operating Ratio--1.0031.056-5%0.947+6%4.699-79%6.222-84%
Pb Ratio2.752-25%3.4313.057+12%2.420+42%4.483-23%5.013-32%
Pe Ratio-107.006+20%-133.42281.692-263%36.622-464%-74.245-44%-55.055-59%
Price Per Share11.950-25%14.90013.373+11%10.463+42%14.120+6%11.963+25%
Price To Free Cash Flow Ratio5350.318-25%6671.1081681.933+297%-15.381+100%321.836+1973%160.071+4068%
Price To Total Gains Ratio-428.025+20%-533.689317.707-268%223.105-339%-235.269-56%-183.379-66%
Quick Ratio--3.2753.676-11%4.966-34%4.818-32%3.710-12%
Return On Assets---0.006-0.004-25%0.006-206%-0.017+185%-0.027+353%
Return On Equity---0.006-0.005-24%0.006-205%-0.019+190%-0.036+458%
Total Gains Per Share---0.028-0.015-47%0.532-105%0.089-131%0.111-125%
Usd Book Value--8771704.0008849559.500-1%8752622.000+0%7271308.900+21%5167880.724+70%
Usd Book Value Change Per Share---0.003-0.001-47%0.050-105%0.008-131%0.010-125%
Usd Book Value Per Share--0.4080.412-1%0.407+0%0.329+24%0.236+73%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.002-25%0.003-203%-0.005+89%-0.006+114%
Usd Free Cash Flow--1128.000-228772.500+20381%-363098.500+32290%-339278.900+30178%-278478.213+24788%
Usd Free Cash Flow Per Share--0.000-0.011+20381%-0.017+32289%-0.016+29928%-0.013+24660%
Usd Free Cash Flow To Equity Per Share--0.000-0.009+18144%-0.017+32181%0.021-100%0.014-100%
Usd Market Cap24140615.640-25%30100041.09127014281.845+11%21135737.659+42%29835073.405+1%24839727.278+21%
Usd Price Per Share1.123-25%1.4011.257+11%0.983+42%1.327+6%1.125+25%
Usd Profit---56400.000-42488.000-25%54708.000-203%-109176.300+94%-122055.250+116%
Usd Revenue--586936.000588205.0000%553425.000+6%283889.400+107%159120.356+269%
Usd Total Gains Per Share---0.003-0.001-47%0.050-105%0.008-131%0.010-125%
 EOD+4 -4MRQTTM+13 -20YOY+15 -185Y+22 -1110Y+22 -11

3.2. Fundamental Score

Let's check the fundamental score of Corline Biomedical AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-107.006
Price to Book Ratio (EOD)Between0-12.752
Net Profit Margin (MRQ)Greater than0-0.096
Operating Margin (MRQ)Greater than0-0.003
Quick Ratio (MRQ)Greater than13.275
Current Ratio (MRQ)Greater than13.505
Debt to Asset Ratio (MRQ)Less than10.068
Debt to Equity Ratio (MRQ)Less than10.073
Return on Equity (MRQ)Greater than0.15-0.006
Return on Assets (MRQ)Greater than0.05-0.006
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Corline Biomedical AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.650
Ma 20Greater thanMa 5012.735
Ma 50Greater thanMa 10013.715
Ma 100Greater thanMa 20013.655
OpenGreater thanClose12.200
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  7,0921,4058,497-3,0225,4751,7267,201-7,222-21



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets100,105
Total Liabilities6,789
Total Stockholder Equity93,316
 As reported
Total Liabilities 6,789
Total Stockholder Equity+ 93,316
Total Assets = 100,105

Assets

Total Assets100,105
Total Current Assets23,797
Long-term Assets76,308
Total Current Assets
Cash And Cash Equivalents 17,012
Net Receivables 5,220
Other Current Assets 1,565
Total Current Assets  (as reported)23,797
Total Current Assets  (calculated)23,797
+/-0
Long-term Assets
Property Plant Equipment 314
Long-term Assets Other 75,993
Long-term Assets  (as reported)76,308
Long-term Assets  (calculated)76,307
+/- 1

Liabilities & Shareholders' Equity

Total Current Liabilities6,789
Long-term Liabilities0
Total Stockholder Equity93,316
Total Current Liabilities
Accounts payable 1,971
Other Current Liabilities 4,818
Total Current Liabilities  (as reported)6,789
Total Current Liabilities  (calculated)6,789
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2,686
Retained Earnings -127,642
Accumulated Other Comprehensive Income 63,079
Other Stockholders Equity 155,193
Total Stockholder Equity (as reported)93,316
Total Stockholder Equity (calculated)93,316
+/-0
Other
Cash and Short Term Investments 17,012
Common Stock Shares Outstanding 21,491
Liabilities and Stockholders Equity 100,105
Net Debt -17,012
Net Working Capital 17,008



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-30
> Total Assets 
0
0
16,773
0
27,393
26,092
24,995
23,704
46,004
43,519
41,275
48,251
43,580
55,209
51,427
47,345
62,070
65,236
62,915
58,006
69,652
66,060
63,751
62,084
60,779
57,085
58,282
70,194
99,984
97,291
101,661
97,297
99,259
101,845
101,783
103,440
101,869
99,353
100,105
100,10599,353101,869103,440101,783101,84599,25997,297101,66197,29199,98470,19458,28257,08560,77962,08463,75166,06069,65258,00662,91565,23662,07047,34551,42755,20943,58048,25141,27543,51946,00423,70424,99526,09227,393016,77300
   > Total Current Assets 
0
0
2,158
0
11,163
9,009
5,564
2,485
22,445
17,996
13,309
17,788
12,326
22,931
18,442
13,667
28,317
31,483
28,992
23,992
35,547
31,908
24,993
19,364
14,937
10,095
10,738
21,591
49,315
44,656
44,819
39,138
39,133
37,804
35,998
34,700
30,628
25,435
23,797
23,79725,43530,62834,70035,99837,80439,13339,13844,81944,65649,31521,59110,73810,09514,93719,36424,99331,90835,54723,99228,99231,48328,31713,66718,44222,93112,32617,78813,30917,99622,4452,4855,5649,00911,16302,15800
       Cash And Cash Equivalents 
0
0
1,645
0
9,960
7,734
4,868
1,364
21,033
16,610
11,864
16,156
11,436
22,506
16,856
11,698
24,551
30,817
27,644
22,799
32,898
27,740
22,857
16,876
12,439
7,847
8,991
19,427
47,705
42,938
41,635
35,585
32,367
28,743
26,210
19,841
21,299
17,000
17,012
17,01217,00021,29919,84126,21028,74332,36735,58541,63542,93847,70519,4278,9917,84712,43916,87622,85727,74032,89822,79927,64430,81724,55111,69816,85622,50611,43616,15611,86416,61021,0331,3644,8687,7349,96001,64500
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
97
137
1,692
2,096
1,917
1,899
1,359
1,212
1,105
1,022
2,295
2,700
2,138
6,246
1,658
9,805
6,453
6,014
5,220
5,2206,0146,4539,8051,6586,2462,1382,7002,2951,0221,1051,2121,3591,8991,9172,0961,6921379700000000000000000000
       Other Current Assets 
0
0
513
0
1,203
1,275
696
1,120
1,412
1,386
1,445
1,632
890
425
1,586
1,969
3,766
666
1,348
1,193
2,649
4,168
2,136
2,488
2,498
2,248
1,747
2,164
1,610
1,718
3,184
3,553
6,766
2,815
0
5,054
2,876
2,421
1,565
1,5652,4212,8765,05402,8156,7663,5533,1841,7181,6102,1641,7472,2482,4982,4882,1364,1682,6491,1931,3486663,7661,9691,5864258901,6321,4451,3861,4121,1206961,2751,203051300
   > Long-term Assets 
0
0
14,615
0
16,230
17,083
19,431
21,219
23,559
25,523
27,966
30,463
31,254
32,278
32,985
33,678
33,753
33,753
33,923
34,014
34,105
34,152
38,758
42,720
45,842
46,990
47,544
48,603
50,669
52,635
56,842
58,159
60,126
64,041
65,785
68,740
71,241
73,918
76,308
76,30873,91871,24168,74065,78564,04160,12658,15956,84252,63550,66948,60347,54446,99045,84242,72038,75834,15234,10534,01433,92333,75333,75333,67832,98532,27831,25430,46327,96625,52323,55921,21919,43117,08316,230014,61500
       Property Plant Equipment 
0
0
31
0
14
5
3
2
2
2
1
1
1
0
0
0
0
0
46
44
42
39
37
35
32
80
73
70
132
194
182
170
186
216
280
360
364
339
314
3143393643602802161861701821941327073803235373942444600000111222351403100
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
27,964
30,461
31,252
0
32,984
33,677
33,752
0
33,876
0
0
0
38,720
42,684
45,809
46,909
47,470
48,532
50,536
52,440
56,659
57,988
59,939
63,824
65,504
68,379
70,876
0
0
0070,87668,37965,50463,82459,93957,98856,65952,44050,53648,53247,47046,90945,80942,68438,72000033,876033,75233,67732,984031,25230,46127,9640000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,062
34,112
38,720
42,684
45,809
46,909
47,470
48,532
50,536
52,440
56,659
57,988
1
63,824
0
0
70,876
0
0
0070,8760063,824157,98856,65952,44050,53648,53247,47046,90945,80942,68438,72034,11234,06200000000000000000000
> Total Liabilities 
0
0
11,288
0
2,846
2,613
3,745
4,289
4,420
3,249
2,529
12,590
9,957
7,589
5,501
3,203
3,862
8,605
7,953
6,011
6,286
4,626
4,433
5,272
6,542
4,998
6,250
4,775
4,384
3,767
9,427
5,915
7,002
7,621
7,194
7,832
8,132
5,437
6,789
6,7895,4378,1327,8327,1947,6217,0025,9159,4273,7674,3844,7756,2504,9986,5425,2724,4334,6266,2866,0117,9538,6053,8623,2035,5017,5899,95712,5902,5293,2494,4204,2893,7452,6132,846011,28800
   > Total Current Liabilities 
0
0
11,288
0
2,846
2,613
3,745
4,289
4,420
3,249
2,529
12,590
9,957
7,589
5,501
3,203
3,862
8,605
7,953
6,011
6,286
4,626
4,433
5,272
6,542
4,998
6,250
4,775
4,384
3,767
9,427
5,915
7,002
7,621
7,194
7,832
8,132
5,437
6,789
6,7895,4378,1327,8327,1947,6217,0025,9159,4273,7674,3844,7756,2504,9986,5425,2724,4334,6266,2866,0117,9538,6053,8623,2035,5017,5899,95712,5902,5293,2494,4204,2893,7452,6132,846011,28800
       Short-term Debt 
0
0
9,313
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000009,31300
       Accounts payable 
0
0
139
0
435
782
1,601
2,292
1,986
1,182
768
1,544
960
1,265
3,235
1,053
978
971
1,761
1,304
1,459
521
818
2,300
2,100
836
1,441
685
1,452
907
1,959
979
1,682
5,380
4,341
4,385
2,979
804
1,971
1,9718042,9794,3854,3415,3801,6829791,9599071,4526851,4418362,1002,3008185211,4591,3041,7619719781,0533,2351,2659601,5447681,1821,9862,2921,601782435013900
       Other Current Liabilities 
0
0
1,837
0
2,412
1,831
2,143
1,997
2,434
2,067
1,761
11,046
8,997
6,324
2,266
2,150
2,884
7,634
6,192
4,707
4,827
4,105
3,615
2,972
4,442
4,162
4,809
4,090
2,932
2,860
7,468
4,936
5,320
2,241
2,853
3,447
5,153
4,633
4,818
4,8184,6335,1533,4472,8532,2415,3204,9367,4682,8602,9324,0904,8094,1624,4422,9723,6154,1054,8274,7076,1927,6342,8842,1502,2666,3248,99711,0461,7612,0672,4341,9972,1431,8312,41201,83700
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,959
979
1,682
5,380
4,341
4,385
0
0
0
0004,3854,3415,3801,6829791,959000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,062
34,112
38,720
42,684
45,809
46,909
47,470
48,532
50,536
52,440
56,659
57,988
59,939
63,824
0
0
70,876
0
0
0070,8760063,82459,93957,98856,65952,44050,53648,53247,47046,90945,80942,68438,72034,11234,06200000000000000000000
> Total Stockholder Equity
0
0
5,485
0
24,547
23,479
21,250
19,415
41,584
40,270
38,746
35,661
33,623
47,620
45,926
44,142
58,208
56,631
54,962
51,995
63,366
61,434
59,318
56,812
54,237
52,087
52,032
65,419
95,600
93,524
92,234
91,382
92,257
94,224
94,589
95,608
93,737
93,916
93,316
93,31693,91693,73795,60894,58994,22492,25791,38292,23493,52495,60065,41952,03252,08754,23756,81259,31861,43463,36651,99554,96256,63158,20844,14245,92647,62033,62335,66138,74640,27041,58419,41521,25023,47924,54705,48500
   Common Stock
0
0
804
0
0
0
1,195
0
0
0
1,593
0
0
0
1,820
0
1,971
1,971
1,971
1,972
2,084
2,084
2,084
2,084
2,084
2,084
2,084
2,274
2,686
2,686
2,686
2,686
2,686
2,686
2,686
2,686
2,686
2,686
2,686
2,6862,6862,6862,6862,6862,6862,6862,6862,6862,6862,6862,2742,0842,0842,0842,0842,0842,0842,0841,9721,9711,9711,97101,8200001,5930001,19500080400
   Retained Earnings Total Equity000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,468
57,965
60,666
63,079
63,07960,66657,96555,46800000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
27,483
0
0
0
20,056
0
0
0
71,048
0
0
0
85,811
0
101,596
101,489
101,489
116,029
115,272
115,272
115,272
119,236
122,360
123,460
115,272
130,937
164,862
166,765
96,470
200,269
202,221
202,221
89,574
155,193
155,193
155,193
155,193
155,193155,193155,193155,19389,574202,221202,221200,26996,470166,765164,862130,937115,272123,460122,360119,236115,272115,272115,272116,029101,489101,489101,596085,81100071,04800020,05600027,48300



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue25,030
Cost of Revenue-25,489
Gross Profit-459-459
 
Operating Income (+$)
Gross Profit-459
Operating Expense-29,111
Operating Income-459-29,570
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense29,1110
 
Net Interest Income (+$)
Interest Income0
Interest Expense-26
Other Finance Cost-2
Net Interest Income-24
 
Pretax Income (+$)
Operating Income-459
Net Interest Income-24
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,809891
EBIT - interestExpense = -485
-1,807
-1,783
Interest Expense26
Earnings Before Interest and Taxes (EBIT)-459-1,783
Earnings Before Interest and Taxes (EBITDA)-362
 
After tax Income (+$)
Income Before Tax-1,809
Tax Provision-0
Net Income From Continuing Ops-870-1,809
Net Income-1,809
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses25,489
Total Other Income/Expenses Net-1,35024
 

Technical Analysis of Corline
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Corline. The general trend of Corline is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Corline's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Corline Biomedical AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 12.65 < 13.95 < 15.00.

The bearish price targets are: 11.50 > 11.50 > 11.05.

Tweet this
Corline Biomedical AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Corline Biomedical AB. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Corline Biomedical AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Corline Biomedical AB. The current macd is -0.4743348.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Corline price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Corline. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Corline price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Corline Biomedical AB Daily Moving Average Convergence/Divergence (MACD) ChartCorline Biomedical AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Corline Biomedical AB. The current adx is 16.39.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Corline shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Corline Biomedical AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Corline Biomedical AB. The current sar is 13.11.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Corline Biomedical AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Corline Biomedical AB. The current rsi is 37.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Corline Biomedical AB Daily Relative Strength Index (RSI) ChartCorline Biomedical AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Corline Biomedical AB. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Corline price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Corline Biomedical AB Daily Stochastic Oscillator ChartCorline Biomedical AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Corline Biomedical AB. The current cci is -70.68095062.

Corline Biomedical AB Daily Commodity Channel Index (CCI) ChartCorline Biomedical AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Corline Biomedical AB. The current cmo is -29.06523155.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Corline Biomedical AB Daily Chande Momentum Oscillator (CMO) ChartCorline Biomedical AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Corline Biomedical AB. The current willr is -78.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Corline is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Corline Biomedical AB Daily Williams %R ChartCorline Biomedical AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Corline Biomedical AB.

Corline Biomedical AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Corline Biomedical AB. The current atr is 0.81633041.

Corline Biomedical AB Daily Average True Range (ATR) ChartCorline Biomedical AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Corline Biomedical AB. The current obv is -252,169.

Corline Biomedical AB Daily On-Balance Volume (OBV) ChartCorline Biomedical AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Corline Biomedical AB. The current mfi is 30.31.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Corline Biomedical AB Daily Money Flow Index (MFI) ChartCorline Biomedical AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Corline Biomedical AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Corline Biomedical AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Corline Biomedical AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.650
Ma 20Greater thanMa 5012.735
Ma 50Greater thanMa 10013.715
Ma 100Greater thanMa 20013.655
OpenGreater thanClose12.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Corline with someone you think should read this too:
  • Are you bullish or bearish on Corline? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Corline? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Corline Biomedical AB

I send you an email if I find something interesting about Corline Biomedical AB.


Comments

How you think about this?

Leave a comment

Stay informed about Corline Biomedical AB.

Receive notifications about Corline Biomedical AB in your mailbox!